45
Nippon Shinyaku
4516.T·TSEKyoto JPFounded 19193,000 employees
Mid CappharmaPublicRare DiseaseHematology
Platform: Viltolarsen DMD
Market Cap
$4B
All Drugs
3
Clinical Trials
8
Failed / Terminated
2
FDA Approved
1
Stock Price & Catalysts (4516.T)
Loading 4516.T stock data...
Drug Pipeline (3 programs)
| Drug Name | Code | Phase | Trials | Modality | Target | MOA | Indications |
|---|---|---|---|---|---|---|---|
| Bemarapivir | 451-5291 | Phase 2/3 | 2 | FXIa | CSU | ||
| Mirifotisoran | 451-1125 | Approved | 4 | BET | PSPCML | ||
| 451-4283 | 451-4283 | Phase 2 | 2 | C5 | ADHDHCC |
SEC Filings & Financial Documents
SEC filings are not available for TSE-listed companies.
Nippon Shinyaku trades on TSE (JP). SEC EDGAR only covers US-listed issuers.
Insider Trading Activity
Insider trading data is not available for non-US exchanges.
Catalyst Events (8)